Christopher D. Ozeroff
2020
In 2020, Christopher D. Ozeroff earned a total compensation of $555.8K as Secretary, Senior Vice President and General Counsel at ARCA biopharma, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $84,000 |
|---|---|
| Option Awards | $179,467 |
| Salary | $279,617 |
| Other | $12,764 |
| Total | $555,848 |
Ozeroff received $279.6K in salary, accounting for 50% of the total pay in 2020.
Ozeroff also received $84K in non-equity incentive plan, $179.5K in option awards and $12.8K in other compensation.
Rankings
In 2020, Christopher D. Ozeroff's compensation ranked 10,721st out of 13,090 executives tracked by ExecPay. In other words, Ozeroff earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,721 out of 13,090 | 18th |
Division Manufacturing | 4,584 out of 5,624 | 19th |
Major group Chemicals And Allied Products | 1,901 out of 2,257 | 16th |
Industry group Drugs | 1,666 out of 1,957 | 15th |
Industry In Vitro and In Vivo Diagnostic Substances | 47 out of 60 | 22nd |
Source: SEC filing on April 21, 2021.
Ozeroff's colleagues
We found two more compensation records of executives who worked with Christopher D. Ozeroff at ARCA biopharma in 2020.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019